News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,519 Results
Type
Article (52247)
Company Profile (297)
Press Release (697975)
Multimedia
Podcasts (93)
Webinars (13)
Section
Business (215822)
Career Advice (2435)
Deals (37080)
Drug Delivery (115)
Drug Development (84296)
Employer Resources (188)
FDA (17204)
Job Trends (16107)
News (365111)
Policy (35663)
Tag
Academia (2834)
Accelerated approval (5)
Adcomms (28)
Allergies (89)
Alliances (52613)
ALS (94)
Alzheimer's disease (1460)
Antibody-drug conjugate (ADC) (138)
Approvals (17189)
Artificial intelligence (286)
Autoimmune disease (25)
Automation (16)
Bankruptcy (376)
Best Places to Work (12275)
BIOSECURE Act (20)
Biosimilars (109)
Biotechnology (204)
Bladder cancer (83)
Brain cancer (30)
Breast cancer (291)
Cancer (2344)
Cardiovascular disease (192)
Career advice (2047)
Career pathing (32)
CAR-T (157)
Cell therapy (439)
Cervical cancer (21)
Clinical research (68357)
Collaboration (872)
Compensation (528)
Complete response letters (25)
COVID-19 (2745)
CRISPR (42)
C-suite (255)
Cystic fibrosis (103)
Data (2231)
Decentralized trials (2)
Denatured (39)
Depression (52)
Diabetes (284)
Diagnostics (6715)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (124)
Drug pricing (116)
Drug shortages (32)
Duchenne muscular dystrophy (98)
Earnings (89394)
Editorial (42)
Employer branding (23)
Employer resources (157)
Events (120266)
Executive appointments (758)
FDA (18504)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (783)
Gene editing (110)
Generative AI (26)
Gene therapy (319)
GLP-1 (796)
Government (4819)
Grass and pollen (4)
Guidances (59)
Healthcare (20142)
Huntington's disease (25)
IgA nephropathy (27)
Immunology and inflammation (126)
Indications (30)
Infectious disease (2897)
Inflammatory bowel disease (144)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (100)
Interviews (400)
IPO (17012)
IRA (49)
Job creations (4255)
Job search strategy (1740)
Kidney cancer (11)
Labor market (41)
Layoffs (503)
Leadership (22)
Legal (8812)
Liver cancer (78)
Lung cancer (336)
Lymphoma (155)
Machine learning (7)
Management (62)
Manufacturing (328)
MASH (71)
Medical device (14437)
Medtech (14442)
Mergers & acquisitions (20621)
Metabolic disorders (740)
Multiple sclerosis (84)
NASH (18)
Neurodegenerative disease (102)
Neuropsychiatric disorders (32)
Neuroscience (2031)
NextGen: Class of 2025 (7109)
Non-profit (4824)
Now hiring (39)
Obesity (400)
Opinion (256)
Ovarian cancer (77)
Pain (92)
Pancreatic cancer (85)
Parkinson's disease (156)
Partnered (21)
Patents (243)
Patient recruitment (113)
Peanut (49)
People (61524)
Pharmaceutical (69)
Pharmacy benefit managers (20)
Phase I (21266)
Phase II (30030)
Phase III (22455)
Pipeline (1208)
Policy (160)
Postmarket research (2776)
Preclinical (9120)
Press Release (70)
Prostate cancer (110)
Psychedelics (35)
Radiopharmaceuticals (258)
Rare diseases (403)
Real estate (6524)
Recruiting (70)
Regulatory (24233)
Reports (50)
Research institute (2533)
Resumes & cover letters (403)
Rett syndrome (5)
RNA editing (5)
RSV (47)
Schizophrenia (77)
Series A (136)
Series B (88)
Service/supplier (13)
Sickle cell disease (53)
Special edition (17)
Spinal muscular atrophy (155)
Sponsored (32)
Startups (3916)
State (2)
Stomach cancer (14)
Supply chain (75)
Tariffs (44)
The Weekly (52)
Vaccines (747)
Venture capitalists (42)
Weight loss (275)
Women's health (40)
Worklife (18)
Date
Today (181)
Last 7 days (895)
Last 30 days (2722)
Last 365 days (34019)
2025 (11026)
2024 (36567)
2023 (41567)
2022 (52796)
2021 (57508)
2020 (56426)
2019 (49695)
2018 (37693)
2017 (34438)
2016 (34371)
2015 (40348)
2014 (34075)
2013 (29333)
2012 (31758)
2011 (32355)
2010 (30707)
Location
Africa (869)
Alabama (54)
Alaska (7)
Arizona (245)
Arkansas (14)
Asia (42555)
Australia (6955)
California (6216)
Canada (2032)
China (547)
Colorado (277)
Connecticut (293)
Delaware (151)
Europe (92052)
Florida (918)
Georgia (214)
Idaho (62)
Illinois (598)
India (26)
Indiana (314)
Iowa (11)
Japan (164)
Kansas (110)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (936)
Massachusetts (4704)
Michigan (227)
Minnesota (407)
Mississippi (2)
Missouri (83)
Montana (29)
Nebraska (25)
Nevada (65)
New Hampshire (69)
New Jersey (1761)
New Mexico (29)
New York (1773)
North Carolina (1050)
North Dakota (8)
Northern California (2700)
Ohio (214)
Oklahoma (14)
Oregon (37)
Pennsylvania (1389)
Puerto Rico (12)
Rhode Island (35)
South America (1290)
South Carolina (23)
South Dakota (1)
Southern California (2331)
Tennessee (103)
Texas (927)
United States (23785)
Utah (189)
Virginia (152)
Washington D.C. (66)
Washington State (575)
West Virginia (3)
Wisconsin (64)
750,519 Results for "medical action industries inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Theralase Discovers New Mechanism of Action of Lead Drug
Theralase(R) Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar’s(TM) Ability to Inhibit DeUbiquitinating Enzymes, an Important Class of Enzymes Which Have Been Linked to Numerous Cancers and Neurogenerative Diseases
April 28, 2025
·
7 min read
Regulatory
FDA Action Alert: Ionis, Lexicon, Bristol Myers Squibb and More
The FDA’s year-end rush includes nine target action dates, mostly for rare disease and cancer therapies.
December 9, 2024
·
7 min read
·
Tristan Manalac
Press Releases
Sun Pharma and Moebius Medical Announce Dual Publications on MM-II’s Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
April 24, 2025
·
5 min read
Regulatory
FDA Action Alert: Amgen, Aldeyra and Argenx
In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.
March 31, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session
March 26, 2025
·
6 min read
Press Releases
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
April 1, 2025
·
5 min read
Drug Development
Diversity at the Forefront: Life Sciences Industry Champions Inclusive Representation
The industry remains unwavering in the commitment to increased clinical trial accessibility and representation.
February 25, 2025
·
1 min read
·
Lori Ellis
Press Releases
Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application
April 29, 2025
·
3 min read
Press Releases
Zevra Announces Publication of MIPLYFFA® Mechanism of Action Manuscript in Molecular Genetics and Metabolism
April 17, 2025
·
8 min read
Press Releases
Barth Syndrome Foundation Calls for Urgent FDA Action Following Elamipretide Delay
April 29, 2025
·
2 min read
1 of 75,052
Next
